COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA

Human alpha-galactosidase variants

RESCUING VOLTAGE-GATED SODIUM CHANNEL FUNCTION IN INHIBITORY NEURONS

Method of Treating Hormonal Disorders Using Injectable Leuprolide

FIBROBLAST THERAPY FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

INTRAPERITONEAL INJECTION OF HUMAN PLACENTA STEM CELLS PROTECT THE BRAIN FROM STROKE INJURY VIA EXOSOME/MICROPARTICLE FORMATION AND ACE2 MAINTENANCE OF BRAIN PERFUSION

SYSTEMIC INJECTION OF SUPERHEATED PERFLUOROCARBON EMULSION TO IMPROVE VENTILATION AND REDUCE VENTILATOR-INDUCED LUNG INJURY

FORMULATION FOR THE USE IN THE SIMULTANEOUS TREATMENT OF COCCIDIAL INFECTIONS AND IRON DEFICIENCIES

Dosing regimen for injectable cetirizine

METHOD OF TREATING BILIARY TRACT CANCER

PHARMACEUTICAL COMPOSITIONS COMPRISING LEVODOPA, A DOPAMINE DECARBOXYLASE INHIBITOR AND A COMT INHIBITOR AND METHOD OF ADMINISTRATION THEREOF

COMPOSITIONS AND METHODS FOR USE OF EFLORNITHINE AND DERIVATIVES AND ANALOGS THEREOF TO TREAT CANCERS, INCLUDING GLIOMAS

Injectable Suspensions

INJECTABLE BUPRENORPHINE FORMULATION

METHOD AND APPARATUS FOR USING OMALIZUMAB

METHOD AND APPARATUS FOR USING OMALIZUMAB

FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY

METHODS OF TREATING ULCERATIVE COLITIS

INFLUENZA VIRUS REPLICATION FOR VACCINE DEVELOPMENT

RECOMBINANT L-ASPARAGINASE

STABLE LIQUID COMPOSITIONS OF GLUCAGON

Effective Doses of CNP Conjugates

FORMULATION, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Ophthalmic Pharmaceutical Composition, Ophthalmic Kit, and Pharmaceutical Application Thereof

GANAXOLONE FOR USE IN TREATMENT OF SUPER REFRACTORY STATUS EPILEPTICUS

Testosterone Ester Triglyceride Formulations

PHARMACEUTICAL COMPOSITIONS OF TESTOSTERONE

METHODS OF TREATMENT

INJECTABLE AND INHALABLE FORMULATIONS

D-Serine Inhibits Neuroinflammation Due To A Brain Injury

METHODS AND COMPOSITIONS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS

TEMPERATURE-BASED TRANSIENT DELIVERY OF NUCLEIC ACIDS AND PROTEINS TO CELLS AND TISSUES

METHODS AND COMPOSITIONS FOR INHIBITING PMP22 EXPRESSION

RNA ENCODING PEPTIDOGLYCAN HYDROLASE AND USE THEREOF FOR TREATING BACTERIAL INFECTION

METHODS OF TREATING CHRONIC SPONTANEOUS URTICARIA USING LIGELIZUMAB

IMMUNOGLOBULINS AND USES THEREOF

METHODS OF PREVENTING, TREATING, OR REDUCING THE SEVERITY OF CORONAVIRUS DISEASE 2019 (COVID-19)

PEPTIDES FOR THE TREATMENT OF CHRONICALLY ACTIVE AUTOIMMUNE INFLAMMATION

COMPOSITIONS AND METHODS OF TREATING CANCER USING LIPID AGONISTS AND RECEPTORS THEREOF

METHODS FOR TREATING NEUROLOGICAL DISEASES

DERIVATIZED CHITOSAN POLYMERS AND METHODS OF TREATING VASCULAR DISORDERS

COMPOSITIONS COMPRISING AXITINIB AND METHODS OF TREATING OCULAR DISORDERS

METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS

METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA

COMPOSITION COMPRISING HER2 ANTIBODY, FORMULATION AND PROCESS OF PREPARATION THEREOF

READY-TO-INFUSE PHENYLEPHRINE COMPOSITIONS

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

MODIFIED U6 PROMOTER SYSTEM FOR TISSUE SPECIFIC EXPRESSION

METHODS OF IMPROVING CARDIOVASCULAR FUNCTION AND TREATING CARDIOVASCULAR DISEASE USING A RECOMBINANT ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE (NPP1)

PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS

TREATMENT OF CANCER WITH ANTI-ILT2 ANTIBODIES

NOVEL POLYPEPTIDES AND MEDICAL USES THEREOF

HETEROCYCLIC AGONISTS

STAT3 DEGRADERS AND USES THEREOF

PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

INJECTABLE SLURRIES AND METHODS OF MANUFACTURING AND USING THE SAME

ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER

THERAPEUTIC AGENT FOR DISC HERNIATION

TREATMENT OF INTERVERTEBRAL DISC DEGENERATION

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES

AMORPHOUS CALCIUM CARBONATE STABILIZED WITH POLYPHOSPHATES OR BISPHOSPHONATES

METHODS FOR TREATMENT OF DISEASES

Antiviral Therapy

PHARMACEUTICAL COMPOSITION FOR TREATING MIGRAINE

METHODS OF TREATING INJURIES OR CONDITIONS RELATED TO CNS EDEMA

POLYMERS AND NANOPARTICLES FOR INTRAMUSCULAR NUCLEIC ACID DELIVERY

RECOMBINANT AAV FORMULATIONS

GENE THERAPY FOR NEURODEGENERATIVE DISORDERS

Anti-CD38 Antibodies for Treatment of Light Chain Amyloidosis and Other CD38-Positive Hematological Malignancies

ANTI-IL36R ANTIBODIES

METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

Safe and Effective Method of Treating Lupus with Anti-IL/IL23 Antibody

ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS

DENDRIMER COMPOSITIONS AND METHODS FOR TREATMENT OF SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME

INJECTABLE PHARMACEUTICAL FORMULATIONS OF LEFAMULIN

HER2 VACCINE COMPOSITION

COMPOSITIONS AND METHODS FOR TREATMENTS BY MODULATION OF EXCITABLE TISSUES ACTIVITIES, AND FOR ANTIMICROBIAL APPLICATIONS

Methods for Regulating Muscle Performance using Fat Specific Protein 27 (FSP27) Compositions

FORMULATIONS OF VANCOMYCIN

METHODS FOR INDUCING VASODILATION

AGENTS ENCODING CLDN6 AND CD3 BINDING ELEMENTS FOR TREATING CLDN6-POSITIVE CANCERS

COMPOSITION CONTAINING ARTESUNATE

DOSAGE FORM FOR INTRA-ARTICULAR INJECTION COMPRISING COLCHICINE FOR USE IN THE TREATMENT OF CRYSTAL-AND NON-CRYSTAL ASSOCIATED ACUTE INFLAMMATORY ARTHRITIS

INJECTABLE SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION

ULTRA LONG ACTING PHARMACEUTICAL COMPOSITION COMPRISING INSULIN

GENETIC MODIFICATION OF MAMMALIAN CELLS TO CONFER RESISTANCE TO CSF1R ANTAGONISTS

MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION THERAPY

TREATMENT OF LUPUS NEPHRITIS WITH ANTI-TYPE I INF RECEPTOR ANTIBODY ANIFROLUMAB

TREATMENT OF CUTANEOUS LUPUS ERYTHEMATOUS

METHOD FOR INHIBITING CARDIAC FIBROBLAST TRANSDIFFERENTIATION

Methods for Treating TNFa-Related Diseases

METHOD OF TREATING OSTEOARTHRITIS

SPIRO-LACTAM NMDA MODULATORS AND METHODS OF USING SAME

6-PYRIMIDIN-ISOINDOLE DERIVATIVE AS ERK1/2 INHIBITOR

Near Infrared Fluorescent Dyes, Formulations and Related Methods

AAV CAPSID VARIANTS AND USES THEREOF

GENE THERAPY FOR GALACTOSEMIA

PEPTIDE SLOW-RELEASE FORMULATIONS

METHODS FOR TREATMENT USING ANTI-ALPHA4BETA7 ANTIBODY

PNEUMOCOCCAL POLYPEPTIDE ANTIGENS

POLYNUCLEOTIDE COMPOSITIONS AND USES THEREOF

METHODS FOR IMPROVING ORGAN FUNCTION IN ORGAN TRANSPLANT PATIENTS

TREATMENT AND PREVENTION OF OSTEOPOROSIS IN HIGH BODY MASS INDEX INDIVIDUALS

Compositions and Methods for Subcutaneous Administration of Cancer Immunotherapy

High-Stability Daptomycin Composition For Injection, And Preparation Method Therefor And Use Thereof

ANTI-INFLAMMATORY VISCOSUPPLEMENTATION AGENT CONTAINING HYALURONIC ACID

METHODS OF TREATMENT OR PREVENTION OF ACUTE BRAIN OR NERVE INJURIES

Formulation of Resiniferatoxin

TREATMENT OF SEPSIS AND SEPTIC SHOCK

NUCLEIC ACID MOLECULE FOR TREATING BIETTI CRYSTALLINE DYSTROPHY AND USE THEREOF

Compositions and Methods for Treating Cag Repeat Diseases

HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS

EARLY INTERVENTION METHODS TO PREVENT OR AMELIORATE TOXICITY

PAN-ELR+ CXC CHEMOKINE ANTIBODIES FOR THE TREATMENT OF HIDRADENITIS SUPPURATIVA

METHOD FOR TREATING A PERIOHERAL ARTERIAL DISEASE

MYOPEPTIDES AND METHODS OF USE IN TREATING HEART FAILURE

ENZYME INHIBITORS AND VIRAL INFECTION THERAPY

BIOLOGICS LABELING SYSTEM AND METHODS THEREOF

Ophthalmic Compositions, and Ocular Uses Thereof, of Indigo Carmine

LONG LASTING EFFECT OF NEW BOTULINUM TOXIN FORMULATIONS

METHODS AND COMPOSITIONS FOR PROVIDING MYOCARDIAL PROTECTION AND TREATING MYOCARDIAL STRESS AND FIBROSIS

AAV-MEDIATED GENE TRANSFER FOR RETINOPATHY

LONG-ACTING INTRA-ARTICULAR DOSAGE FORMS CONTAINING FLUTICASONE PROPIONATE AND USE THEREOF

CDC7 KINASE INHIBITORS AND USES THEREOF

METHOD OF INITIATING OR ESCALATING DOFETILIDE DOSE AND FORMULATIONS THEREFOR

STABLE AQUEOUS CAPSAICIN INJECTABLE FORMULATIONS AND MEDICAL USES THEREOF

USE OF NANOPARTICLES FOR THE TREATMENT OF FISTULIZING ANOPERINEAL LESIONS

N-ACETYLCYSTEINE COMPOSITIONS AND METHODS

IMMUNOTHERAPIES FOR THE TREATMENT OF CANCER

POLYMER PARTICLES

PD-1/TIM-3 BINDING PROTEINS FOR TREATMENT OF NSCLC and cHL

HUMAN AMYLIN ANALOG POLYPEPTIDES AND METHODS OF USE

VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES

DISULFIDE OLIGOSACCHARIDE COMPOUNDS AND COMPLEXES

MODULATION OF EXTRACELLULAR VESICLES WITH ELECTRICAL STIMULATION

MICROPOROUS ANNEALED PARTICLE GEL SYSTEM

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR KNOCKING OUT C5

THERAPEUTIC RNA FOR LUNG CANCER

ARGINASE AND ARGININOSUCCINATE SYNTHASE FOR CANCER THERAPY

Semaglutide in medical therapy

STABLE INJECTABLE COMPOSITIONS OF GLP-2 PEPTIDE

METHODS AND COMPOSITIONS FOR TREATING CHRONIC LUNG DISEASES

DAPTOMYCIN FORMULATIONS CONTAINING A COMBINATION OF SORBITOL AND MANNITOL

TERMINAL EFFECTOR T CELLS, PROCESS FOR THEIR PRODUCTION AND THEIR ISOLATION AND THEIR THERAPEUTIC USE

MICRORNA-BASED PARTICLE FOR THE TREATMENT OF DYSREGULATED IMMUNE RESPONSE

NICOTINAMIDE RIBOSIDE AND DERIVATIVES THEREOF IN INTRAVENOUS FORMULATIONS AND METHODS OF USE THEREOF

FORMULATIONS AND METHODS FOR TREATING CONDITIONS OF THE EYE

USES OF TRI-SUBSTITUTED HETEROARYL DERIVATIVES AS SRC HOMOLOGY-2 PHOSPHATASE INHIBITORS

SMALL MOLECULE TRAIL GENE INDUCTION BY NORMAL AND TUMOR CELLS AS AN ANTICANCER THERAPY

TLR7 AGONIST AND COMBINATIONS FOR CANCER TREATMENT

COMPOSITIONS, SYSTEMS AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND LOSARTAN

COMPOSITIONS, SYSTEMS AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND CALCIUM CHANNEL BLOCKERS

COMPOSITIONS, SYSTEMS AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND ANTI-FIBROTIC AGENTS THAT ARE NON-TUMORIGENIC

METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS

A COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL DISC HERNIATION

USE OF D-ARABITOL IN LIPID-LOWERING AND HEPATOPROTECTION

CONDITION-ACTIVATABLE NUCLEIC ACID CONSTRUCTS AND THEIR USES FOR TREATING NEUROLOGICAL DISEASES

MODELS OF TAUOPATHY

METHODS FOR THE TREATMENT AND PREVENTION OF GPP

VEGFR-FC FUSION PROTEIN FORMULATIONS

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS

GUAIANOLIDE OLIGOMERS, PREPARATION METHOD AND APPLICATION

CLOSED-LOOP SODIUM ADMINISTRATION FOR TREATMENT OF CEREBRAL EDEMA

PERFUSION SYSTEM

NON-PEPTIDE TARGETED THERAPEUTICS AND USES THEREOF

TREATMENT OF HEREDITARY ANGIOEDEMA WITH AAV GENE THERAPY VECTORS AND THERAPEUTIC FORMULATIONS

METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING A CARTILAGE DAMAGE USING SOX9 GENE

NUCLEIC ACID VACCINES

IONIC LIQUIDS FOR DRUG DELIVERY

BIOCHEMICAL AND BIOMECHANICAL CONDITIONING FOR ENHANCING PERSONALIZED MESENCHYMAL STEM CELL THERAPIES

PHARMACEUTICAL HYDROCORTISONE SOLUTION FOR INJECTION DEVICE

METHOD OF TREATMENT AND DOSAGE FORMS THEREOF

COMPOSITIONS FOR THE EFFECTIVE TREATMENT OF VITAMIN C DEFICIENCY-RELATED DISEASES AND OTHER CONDITIONS

LIPID-BASED RNA FORMULATIONS SUITABLE FOR THERAPY

PREPARATION METHOD AND APPLICATION METHOD OF INJECTABLE PLA MICROSPHERES

THROMBOLYTIC MICROSPHERES TO DISSOLVE VASO-OCCLUSIVE CLOTS

PREPARATION FOR USE IN A METHOD FOR THE TREATMENT AND/OR PREVENTION OF A DISEASE

METHOD FOR PREPARING PREFILLED SYRINGE FORMULATION

IVALTINOSTAT COMBINATION THERAPY FOR TREATING PANCREATIC CANCER

Anti-PfRH5 Antibodies and Antigen-Binding Fragments Thereof

METHODS OF TREATING NON-HODGKIN LYMPHOMA USING 2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE

TREATMENT OF HSV-2 USING A MEGANUCLEASE

NOVEL NANOPARTICLES OF ANTIRETROVIRAL DRUGS, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRAL INFECTIONS

Compositions and Methods for Treating Dopamine Disorders

Compositions and Methods for Treating Dopamine Disorders

ADDITIVES FOR PROTEIN FORMULATIONS TO IMPROVE THERMAL STABILITY

NUCLEIC ACID VACCINES

NUCLEIC ACID VACCINES

COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR GENERATING AN IMMUNE RESPONSE TO TREAT OR PREVENT MALARIA

PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF

GROUP B ADENOVIRUS-CONTAINING FORMULATION

CELL-FREE LIPOASPIRATE-DERIVED PREPARATION, COMPOSITIONS INCLUDING THE PREPARATION AND USES THEREOF

VISCOSUPPLEMENT COMPOSITIONS

MELOXICAM COMPOSITION, PHARMACEUTICAL PREPARATION, AND PREPARATION METHOD AND USE THEREOF

THERAPEUTIC AGENT COMPOSITION AND METHOD OF USE, FOR TREATING, RELIEVING, OR ALLEVIATING ALZHEIMER'S DISEASE

METHODS OF TREATING RBP4 RELATED DISEASES WITH TRIAZOLOPYRIDINES

USE OF PRIDOPIDINE FOR TREATING RETT SYNDROME

CATIONIC POLYMERS

MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION

NEUROPROTECTIVE LIPOSOME COMPOSITIONS AND METHODS FOR TREATMENT OF STROKE

INJECTABLE FORMULATIONS OF APREPITANT

Methods of T Cell Expansion and Activation

SYSTEM AND METHOD FOR TREATMENT OF BONE

FACILITATED DELIVERY OF CONCENTRATED ANTIBODY FORMULATIONS USING HYALURONIDASE

METHOD OF TREATING MULTIPLE MYELOMA

HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION

ANTI-IL-23P19 ANTIBODY REGULATION OF GENES INVOLVED IN BOWEL URGENCY IN ULCERATIVE COLITIS

METHODS AND COMPOSITIONS FOR TREATING PLAQUE PSORIASIS

MATERIALS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA

COMPOUNDS AS GLP-1R AGONISTS

RNA CONSTRUCTS AND USES THEREOF

PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST, AN INSULIN AND METHIONINE

Nucleic acid vaccines

Treatment of Adults With Overweight or Obesity With or Without Weight-Related Comorbidities

METHODS OF MANUFACTURING INJECTABLE SUSTAINED RELEASE FORMULATIONS

OKRA-DERIVED ANTIVIRAL COMPOSITION AND USES THEREOF

PARTICLE-MEDIATED DELIVERY OF BIOLOGICS

COMPOSITION AND METHODS FOR TREATING AN ANEURYSM

STABLE LIQUID COMPOSITIONS OF NETUPITANT AND PALONOSETRON

METHODS OF TREATING AND PREVENTING NEURODEGENERATIVE DISEASES WITH HGF ACTIVATING COMPOUNDS

RUMINANT COMPOSITIONS

RECOMBINANT HCMV VECTORS AND USES THEREOF

FORMULATION FOR MULTI-PURPOSE APPLICATION

Benzimidazole Pyridine Derivatives

Self-Administered Injection Device And Method

VIRUS COMPOSITIONS TO EFFICIENTLY TARGET THE NERVOUS SYSTEM AND THE LUNGS

CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF

MAGNETIC PARTICLE CONTROL AND VISUALIZATION

METHODS OF TREATING OVARIAN CONDITIONS AND DISEASES

THERAPEUTIC CONSTRUCTS FOR CO-DELIVERY OF ANTI-CANCER AGENT(S) AND IMMUNE CHECKPOINT INHIBITOR(S)

PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS

ANTIPARASITIC ISOXAZOLINE COMPOUNDS, LONG-ACTING INJECTABLE FORMULATIONS COMPRISING THEM, METHODS AND USES THEREOF

LEVOTHYROXINE LIQUID FORMULATIONS

COMPOSITION COMPRISING PD-L1 ANTIGEN-BINDING FRAGMENT AND USE THEREOF

OPTIMIZED AP4M1 POLYNEUCLEOTIDES AND EXPRESSION CASSETTES AND THEIR USE

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF ANGIOPOIETIN-LIKE 3 (ANGPTL3) PROTEIN

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COLON CANCER INCLUDING EXTRACELLULAR VESICLES LOADED WITH MACC1 INHIBITOR AS ACTIVE INGREDIENT

POLYNUCLEOTIDES ENCODING URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1 FOR THE TREATMENT OF CRIGLER-NAJJAR SYNDROME

HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION

COMPOSITIONS AND METHODS FOR TREATING LATE STAGE LUNG CANCER

COMPOSITIONS AND METHODS FOR DIAGNOSING AND/OR TREATING KIDNEY INJURY

AAV capsid variants and uses thereof

Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1

METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1

METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1

METHODS AND FORMULATIONS RELATED TO THE INTRATHECAL DELIVERY OF ONCOLYTIC VIRUSES

BIOACTIVE MOLECULES FOR USE IN TREATING INSULIN RESISTANCE AND/OR RESTORING GLUCOSE HOMEOSTASIS

PARENTERAL LIQUID PREPARATION COMPRISING CARBAMATE COMPOUND

METHODS FOR TREATING MUCOPOLYSACCHARIDOSIS

RIBOSE CATIONIC LIPIDS

METHODS FOR DOSE INITIATION OF ARIPIPRAZOLE TREATMENTS

MUC16 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

CD40L-SPECIFIC TN3-DERIVED SCAFFOLDS FOR USE IN THE TREATMENT AND PREVENTION OF RHEUMATOID ARTHRITIS

OPTIMIZED ANTI-TL1A ANTIBODIES

A MYOSTATIN PATHWAY INHIBITOR IN COMBINATION WITH A GLP-1 PATHWAY ACTIVATOR FOR USE IN TREATING METABOLIC DISORDERS

COMPOSITION AND METHODS FOR GENERATING A DERMAL FILLER

TREATMENT OF PROSTATE CANCER WITH RADIOLABELED ANTIBODIES TARGETING CDCP1

TREATMENT OF BLADDER CANCER WITH RADIOLABELED ANTIBODIES TARGETING CDCP1

LANTHANIDE COMPLEX FORMULATIONS

COMPOSITIONS AND SYSTEMS FOR RNA-PROGRAMMABLE CELL EDITING AND METHODS OF MAKING AND USING SAME

ASH1L degraders and methods of treatment therewith

TROPICAL DISEASE VACCINES

METHOD FOR MANAGING PAIN

Long-Acting Growth Hormone Treatment

Treatment of Diabetes Mellitus

COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE

Methods and Compositions for Treatment of Angiogenic Disorders Using Anti-VEGF Agents

rhApoE2 COMPOSITIONS AND METHODS OF USING THE SAME TO TREAT METABOLIC DISEASE AND NEURODEGENERATIVE DISEASE

METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1

COMPOSITIONS FOR ENHANCING IMMUNOTHERAPY EFFICACY IN COLORECTAL CANCER TREATMENT

TUMORICIDAL AND ANTIMICROBIAL COMPOSITIONS AND METHODS

COMPOSITION COMPRISING SODIUM HYALURONATE AND AMINO ACIDS FOR USE IN THE ORTHOPEDIC FIELD

TREATMENT OF DRUG RESISTANT PROLIFERATIVE DISEASES WITH TELOMERASE MEDIATED TELOMERE ALTERING COMPOUNDS

METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS

METHOD FOR TREATING INFLAMMATORY DISORDERS

PHENYLEPHRINE HYDROCHLORIDE COMPOSITIONS AND CONTAINERS

Compositions Of Dimethyl Trisulfide (DMTS) As A Cyanide Antidote

NANOPARTICLE DELIVERY SYSTEMS

Methods of Treating Neurologic Disorders

MICRORNA-29 COMPOUNDS, COMPOSITIONS AND USES IN THERAPY, AND METHODS FOR EVALUATING TENDINOPATHIC LESIONS

ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF

Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-4R) Antibodies

ANTI-CD19 ANTIBODY IN THE TREATMENT OF CNS LYMPHOMA

FUSION PROTEIN OF INTERLEUKIN-2 AND APPLICATION THEREOF IN ALS

PHARMACEUTICAL SALTS OF A CHK-1 INHIBITOR

LANTHANIDE COMPLEX FORMULATIONS

USE OF MECP2 AS BIOMARKER FOR DEPRESSION DIAGNOSIS AND DEPRESSION TREATMENT TARGET

DEVICES FOR CONTROLLING MAGNETIC NANOPARTICLES TO TREAT FLUID OBSTRUCTIONS

VACCINATION AGAINST FUNGAL EPITOPES TO PREVENT INFLAMMATORY BOWEL DISEASES

FORMULATIONS OF FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF

COMPOSITIONS AND METHODS FOR IMPROVED TREATMENT OF DISORDERS AFFECTING THE CENTRAL NERVOUS SYSTEM

PEPTIDES AND METHODS OF TREATING DYSTROPHY-RELATED DISORDERS USING THE SAME

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNITY, INCLUDING AUTOIMMUNITY ASSOCIATED WITH CANCER AND CANCER THERAPY

EXTRAHEPATIC DELIVERY

Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin

SUSTAINED-RELEASE INJECTION PREPARATION CONTAINING DONEPEZIL AND PREPARATION METHOD THEREFOR

COMPOSITION FOR SUSTAINED-RELEASE INJECTION COMPRISING DESLORELIN

NANOPARTICLES FOR CANCER TREATMENT